Abel Hall LLC’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7K Buy
32,348
+22,110
+216% +$7.29K ﹤0.01% 282
2025
Q1
$3.19K Buy
+10,238
New +$3.19K ﹤0.01% 201